ARTICLES BY THIS AUTHOR
- 3/24/2020
Cumberland to support treating patients with hospital-acquired and ventilator-associated pneumonia
Cumberland Pharmaceuticals is taking actions to support hospitals and clinics treating patients with hospital acquired and ventilator associated pneumonia associated with COVID-19. - 3/24/2020
CVS Caremark takes steps to protect supply of medicines potentially useful for COVID-19 treatment
CVS Health is taking additional steps to limit stockpiling of drugs that are used to treat chronic conditions as interest in off-label use of these medicines to treat COVID-19 grow. - 3/24/2020
Hy-Vee, Kroger install temporary protective windows at checkout
Hy-Vee and Kroger have installed temporary window panels at checkouts in response to the COVID-19 outbreak. - 3/23/2020
Camber launches generic Lyrica
Camber's generic Lyrica is available in dosage strengths of 25, 50, 75, 100, 150, 200, 225, and 300 mg. - 3/23/2020
Avion introduces Gloperba
Avion's Gloperba in a liquid oral solution is now available to treat gout. - 3/23/2020
McKesson strategy exec to depart
McKesson is conducting a search for Bansi Nagji's successor, who is stepping down as executive vice president and chief strategy and business development officer, on March 31. - 3/23/2020
FDA institutes shortened approval pathway for biosimilars
The FDA has enacted a shortened regulatory pathway for certain biologics, which will allow for faster approvals and increased competition. - 3/22/2020
Lupin launches generic Diprolene
Betamethasone dipropionate ointment had a market value of approximately $21 million, according to IQVIA January 2020 data. - 3/22/2020
Dr. Reddy's debuts generic Daraprim
Daraprim (pyrimethamine) had a market value of approximately $10 million for the most recent 12 months ended January 2020, according to IQVIA. - 3/22/2020
Generic drug patent cases disrupted by COVID-19
The 30-month stay deadline surrounding generic drug patent disputes is being hampered by courts limiting access and attorneys cutting back on travel.